Other
American College of Allergy, Asthma and Immunology
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
50.0%-37% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
Failure Rate
50.0%
2 terminated/withdrawn out of 4 trials
Success Rate
50.0%
-36.5% vs industry average
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed trials have results
Key Signals
2 with results
Enrollment Performance
Analytics
N/A
1(33.3%)
Phase 1
1(33.3%)
Phase 4
1(33.3%)
3Total
N/A(1)
Phase 1(1)
Phase 4(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT05010304Phase 4Completed
Penicillin De-labeling in the Pediatric Primary Care Setting
Role: collaborator
NCT01989897Phase 1Withdrawn
Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin Tests
Role: collaborator
NCT01264601Not ApplicableCompleted
Safe Administration of Flu Vaccine to Egg Allergic Children
Role: collaborator
NCT00662051Withdrawn
Oral Contraceptives and Asthma Control
Role: collaborator
All 4 trials loaded